These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia. Shioiri T, Kato T, Inubushi T, Murashita J, Takahashi S. Psychiatry Res; 1994 Dec; 55(4):223-35. PubMed ID: 7701036 [Abstract] [Full Text] [Related]
25. Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy. Fukuzako H. World J Biol Psychiatry; 2001 Apr; 2(2):70-82. PubMed ID: 12587188 [Abstract] [Full Text] [Related]
26. Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Hamakawa H, Kato T, Shioiri T, Inubushi T, Kato N. Psychol Med; 1999 May; 29(3):639-44. PubMed ID: 10405085 [Abstract] [Full Text] [Related]
36. Lithium does not alter the choline/creatine ratio in the temporal lobe of human volunteers as measured by proton magnetic resonance spectroscopy. Silverstone PH, Hanstock CC, Rotzinger S. J Psychiatry Neurosci; 1999 May; 24(3):222-6. PubMed ID: 10354656 [Abstract] [Full Text] [Related]
37. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. Yacubian J, de Castro CC, Ometto M, Barbosa E, de Camargo CP, Tavares H, Cerri GG, Gattaz WF. Schizophr Res; 2002 Dec 01; 58(2-3):117-22. PubMed ID: 12409151 [Abstract] [Full Text] [Related]